InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,009.29
(
-1.23%
)
US TECH 100
16,783.60
(
-1.62%
)
Dow Jones
37,859.62
(
-1.56%
)
Brent Oil
86.57
(
-0.75%
)
Bitcoin
63,639.86
(
-1.00%
)
Post# of 1509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

joseytheoutlawwales

Send PM Follow Ignore
Followers 132
Posts 7808
Boards Moderated 0
Alias Born 12/17/2009

joseytheoutlawwales

Re: Citrati post# 169

Friday, 11/17/2017 10:24:19 AM

Friday, November 17, 2017 10:24:19 AM

Post# of 1509
Yes it is. I just know the Co has enough free cash to weather the storm, and with the initial buyout btw greatbatch/integer for $200 million, current MC at $80 is undervalued from values set several years ago prior to some substantial revenue growth and individual market penetration.

Just FYI, the new MedTronic Intellis system is solid and competitive, brings them back into the equation.
However, lack of fractionalized current and only 16 contacts, still places Nuvectra and Boston Sci in the lead IMO.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up